STIM.NASDAQNeuronetics, INC

Form 4: Neuronetics Executive Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Neuronetics EVP, CLO, and CS William Andrew Macan sold 3,427 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

  • William Andrew Macan, Executive Vice President, Chief Legal Officer, and Corporate Secretary of Neuronetics, Inc. (STIM), reported a sale of common stock.
  • The transaction involved the disposition of 3,427 shares of common stock on February 26, 2026.
  • The shares were sold at a weighted average price of $1.35 per share, with individual transaction prices ranging from $1.31 to $1.38.
  • The sale was non-discretionary and conducted to satisfy tax withholding obligations upon the vesting of a portion of a restricted stock unit award.
  • Following this transaction, William Andrew Macan beneficially owns 880,134 shares of Neuronetics common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports a routine, non-discretionary transaction for tax purposes, which does not provide new insights into the company's operational performance or strategic direction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

  • The sales reported were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.

Industry Context

StockSavvy.ai notes that insider sales to cover tax obligations upon the vesting of restricted stock units are a common and routine occurrence in executive compensation across various industries. Such transactions typically do not reflect a change in an executive's sentiment towards the company's prospects but rather a standard administrative event.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, non-discretionary sale for tax purposes and does not signal a change in the executive's investment thesis or company fundamentals.

Key Dates

DateDescription
02/26/2026Date of transaction (sale of common stock).
02/27/2026Date the Form 4 was signed by Attorney-in-Fact.

Recommendation

hold

The filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of restricted stock units. This transaction does not reflect a change in the executive's investment conviction or the company's fundamentals, thus it provides no new information to warrant a change in investment recommendation.

Keywords

Neuronetics, STIM, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.